Novartis AG (NVS)

162.67 -1.25 (-0.76%) USD  |  NYSE  |  Feb 20, 16:00
163.12 +0.45 (+0.28%) Pre-Market: 08:02
More

Novartis Ending Cash (Quarterly)

Ending Cash (Quarterly) Chart

View Ending Cash (Quarterly) for NVS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Ending Cash (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Ending Cash (Quarterly) Range, Past 5 Years

View Ending Cash (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Ending Cash (Quarterly) Benchmarks

View Ending Cash (Quarterly) Benchmarks
Start Trial
Roche Holding AG --
Amgen, Inc. Upgrade
AstraZeneca PLC Upgrade
Gilead Sciences, Inc. --
Regeneron Pharmaceuticals, Inc. Upgrade